Lantheus Holdings (NASDAQ:LNTH) shares are trading higher after the company received FDA approval of PYLARIFY injection.
Lantheus is currently up 15.06% to a price of $22.32. Thursday the stock has been traded at a volume of 4.70 million, about 642.3% of its recent 30-day volume average of 731.50 thousand.
The 50-day moving average price of Lantheus Holdings's stock was $21.28 when this article was published. The stock reached a high of $24.26 and a low of $10.52 in the past 52 weeks.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
